2010
DOI: 10.1016/j.biomaterials.2009.11.082
|View full text |Cite
|
Sign up to set email alerts
|

Controlling the release of peptide antimicrobial agents from surfaces

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
218
0
1

Year Published

2011
2011
2015
2015

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 251 publications
(222 citation statements)
references
References 50 publications
3
218
0
1
Order By: Relevance
“…This can be achieved by impregnating the surface with an antimicrobial agent or using functionalized coatings that allow a localized antimicrobial delivery (Zilberman and Elsner 2008; Shukla et al 2010;Yala et al 2011). As reviewed by Glinel et al (2012), several AMP-based coatings have been tested successfully.…”
Section: Anti-biofilm Antimicrobial Peptide Strategiesmentioning
confidence: 99%
“…This can be achieved by impregnating the surface with an antimicrobial agent or using functionalized coatings that allow a localized antimicrobial delivery (Zilberman and Elsner 2008; Shukla et al 2010;Yala et al 2011). As reviewed by Glinel et al (2012), several AMP-based coatings have been tested successfully.…”
Section: Anti-biofilm Antimicrobial Peptide Strategiesmentioning
confidence: 99%
“…These studies show that it is possible to incorporate and locally release AMPs while retaining antimicrobial activity, although broad-spectrum AMPs such as human lactoferrin 1-11 may not be as potent as conventional antibiotics such as gentamicin [44][45][46]. Shukla et al [47] incorporated a different AMP, ponericin G1, into a degradable polyectrolyte multilayer film that has applications as coatings for medical devices and wound healing. Controlled release over 10 d was achieved with tunable release profiles and retention of antimicrobial activity [47].…”
Section: Alternatives To Conventional Antibioticsmentioning
confidence: 99%
“…Furthermore, the same approach with PEM coatings could be applied to other biodegradable membranes and scaffolds, as we have described previously. Previous studies have demonstrated the compatibility of the poly(β-amino ester) family in vitro and in vivo (31,32). PAA is a well-characterized weak Data are means ± SEM (n = 5 implants per group).…”
Section: Discussionmentioning
confidence: 99%